Antihistamines News and Research

RSS

Allergy medication restores nervous system function in patients with chronic MS

In a remarkably rapid translation of laboratory research findings into a treatment with the potential to benefit patients, UC San Francisco scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic multiple sclerosis (MS).

11 Oct 2017

New study reveals safety of oral food challenges for detecting food allergies

The best way to find out if someone has a food allergy is through an oral food challenge (OFC) where the person is given a very small dose of the food by mouth under the supervision of a board-certified allergist to test for a severe reaction.

7 Sep 2017

Older people treated with electroconvulsive therapy for depression may not get relief from insomnia

Older people receiving electroconvulsive therapy for their depression likely will need an additional treatment if insomnia is one of their symptoms, researchers report.

16 Aug 2017

Study finds fewer than half the children receive epinephrine prior to arriving at ED

Anyone suffering a severe allergic reaction (anaphylaxis) should receive epinephrine as quickly as possible. A new study showed that even kids who were prescribed an epinephrine auto injector didn't receive the life-saving medication when they needed it.

12 Jul 2017

BSACI to publish updated guidance on diagnosis, management of allergic and non-allergic rhinitis

The Standards of Care Committee of the British Society for Allergy & Clinical Immunology is to publish updated guidance on the diagnosis and management of allergic and non-allergic rhinitis. Allergic rhinitis is common and affects between 10-15% of children and 26% of adults in the UK.

10 Jul 2017

New nanoallergen technology could help provide clear, accurate assessment of peanut allergies

Researchers have developed a novel platform to more accurately detect and identify the presence and severity of peanut allergies, without directly exposing patients to the allergen, according to a new study published in the journal Scientific Reports.

27 Jun 2017

Summer perils and ways to avoid, treat them

Summer can bite. It can burn or itch. It can make you extremely sick…or worse.

27 May 2017

Steroids offer no additional relief to emergency patients suffering from hives

Despite standard use for the itching associated with urticaria (commonly known as hives), prednisone (a steroid) offered no additional relief to emergency patients suffering from hives than a placebo did, according to a randomized, placebo-controlled, double-blind, parallel-group study published online yesterday in Annals of Emergency Medicine.

4 May 2017

FDA approves first drug for treating rare form of Batten disease

The U.S. Food and Drug Administration today approved Brineura (cerliponase alfa) as a treatment for a specific form of Batten disease. Brineura is the first FDA-approved treatment to slow loss of walking ability in symptomatic pediatric patients 3 years of age and older with late infantile neuronal ceroid lipofuscinosis type 2 (CLN2), also known as tripeptidyl peptidase-1 (TPP1) deficiency.

27 Apr 2017

Parents face difficulty in choosing right allergy medication for their kids

Tulips, songbirds and itchy little eyes – all are sure signs of spring. As allergy season kicks into high gear, many parents are likely searching for over-the-counter medications to help relieve children of symptoms like sneezing, coughing and congestion.c

17 Apr 2017

Pharmaceuticalization of today’s sleep

The pharmaceuticalisation of sleep, put simply, refers to the ways in which sleep becomes a site for manipulation or augmentation through pharmaceutical use. There are different ways in which sleep can be pharmaceuticalised – for example we can use pharmaceuticals to induce sleep, to consolidate broken sleep, or to prevent or delay sleep.

4 Apr 2017

Early start of pollen season could affect people with allergies

The good news for those who suffer from seasonal allergies is that the misery may be delayed by the snow and cold that crept in mid-March.

30 Mar 2017

New research shows how to prevent prions from growing into deadly diseases

Prion diseases are scary, incurable and fatal. They first gained notoriety when cows became infected by prion proteins and, in turn, infected people. Fervor surrounding mad cow disease resulted in the U.S. banning imports of beef from the European Union for 15 years.

21 Mar 2017

Three-year course of treatment could banish symptoms of hay fever, study finds

Patients blighted by hay fever could markedly reduce symptoms for several years after a three-year course of treatment, but not after two years of treatment, researchers have found.

14 Feb 2017

Plant-based drug for hemophilia shows promise in animal models

People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.

13 Feb 2017

Consuming whole grains has modest effects on gut microbiota and immune response, study finds

In a clinical trial, adults who consumed a diet rich in whole grains rather than refined grains had modest improvements in healthy gut microbiota and certain immune responses. The research was conducted in tandem with a study that looked at the effects of a whole-grain diet on energy metabolism.

9 Feb 2017

Anticholinergic drugs linked to increased rate of emergency department and hospital visits

Anticholinergic medications, a class of drugs very commonly used by older adults, are linked to an increased rate of emergency department and hospital utilization in the United States, according to an Indiana University Center for Aging Research, Indiana University Center for Health Innovation and Implementation Science, and Regenstrief Institute study of community-dwelling Americans age 65 and older.

21 Dec 2016